ROTEM and Dietary Supplements
Primary Purpose
Dietary Supplements, Bleeding Tendency; Due to Coagulation Defect
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ginger
Garlic
Ginkgo Biloba
Ginseng
Placebo
Sponsored by
About this trial
This is an interventional diagnostic trial for Dietary Supplements focused on measuring Dietary supplements, Bleeding tendency
Eligibility Criteria
Inclusion Criteria:
- Age 18-60 years
- Both males and females
- Healthy volunteers
- Smokers and Non-smokers
- Staff frequenting the theatre complex at Steve Biko Academic Hospital
Exclusion Criteria:
- Use of any medication, excluding oral contraceptive pills, in the two week period prior to commencement of the study. Medicines excluded, include aspirin, dietary supplements, herbal teas, anticoagulants and other non-steroidal anti-inflammatory medications. . Oral contraceptive pills were omitted as an exclusion criteria, taking into account that the majority of woman use these. The results of the study will be a better reflection of the effect of these dietary supplements in the modern day woman. Its coagulant properties will be taken into account during data analysis.
- History of any chronic medical or psychiatric illness.
- Current excessive alcohol intake - more than 14 units a week in woman and more than 21 units a week in men.
- Pregnant or lactating mothers.
- Possible planned surgery during the study period
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm Type
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Placebo Comparator
Arm Label
Ginger
Garlic
Ginkgo Biloba
Ginseng
Placebo
Arm Description
Ginger ( Zingiber officinale) 4 grams po dly for 14 days
Garlic (Allium sativum) 4-12 mg alliin po dly for 14 days
Ginkgo Biloba 40mg po tds for 14 days
Ginseng 400mg po dly for 14 days
Placebo po dly for 14 days
Outcomes
Primary Outcome Measures
Platelet dysfunction determined by ROTEM when consuming ginger, garlic, ginkgo biloba and ginseng.
To determine if viscoelastic point-of-care coagulation monitoring (ROTEM) detects abnormalities in platelet function when subjects consume ginger, garlic, ginkgo biloba and ginseng within their recommended daily allowances. ExTEM and FibTEM analysis will be performed and difference in MCF values will determine if there is platelet dysfunction or not.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03125551
Brief Title
ROTEM and Dietary Supplements
Official Title
Viscoelastic Point-of-Care Coagulation Monitoring and Dietary Supplements: A Randomized, Double-blind, Placebo-controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2018
Overall Recruitment Status
Withdrawn
Why Stopped
Study requires Medicines Control council approval
Study Start Date
June 2017 (Anticipated)
Primary Completion Date
July 2017 (Anticipated)
Study Completion Date
August 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pretoria
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Dietary Supplements can affect platelet activation and aggregation, which could result in bleeding tendencies. This study wishes to evaluate the influence that these supplements has on platelet function using Rotational thromboelastometry.
Detailed Description
The WHO informs us that more than 80% of patients in Africa use traditional/herbal medicines as their primary source of health care. The Mayo Clinic stated that nearly 40% of adults reported using complementary and alternative medicine (CAM). Many of these herbal medicines as well as dietary supplements have effects on the coagulation cascade and have been identified as such using laboratory tests including aPTT, PT, INR, light transmission aggregometry and impedence aggregometry to mention but a few.
This study wishes to evaluate coagulation abnormalities using viscoelastic point-of-care coagulation monitoring in this population. This test is readily available in large hospitals and academic settings and is increasingly being used in perioperative medicine. It provides information on coagulation and thrombolysis with minimal delay when compared to other laboratory-based coagulation tests.
The dietary supplements which will be evaluated in this study are ginger, garlic, gingko biloba and ginseng. These four herbal supplements were identified as the most commonly used substances known to modulate the coagulation system. These herbal supplements will be investigated within their maximum daily allowance dosages.
A five-armed placebo-controlled study will be undertaken and study subjects will be recruited on a volunteer basis. Subjects will be divided into five groups and each group will receive one of the four dietary supplements and the fifth group placebo, for a two week period. Rotational thromboelastometry (ROTEM) studies will be performed on blood samples obtained from each participant at baseline and at the end of the treatment period to identify coagulation abnormalities. Most of these herbal medicines have been identified to affect platelet function and this study will specifically look at platelet function determined by maximum clot firmness (MCF) in the ROTEM analysis.
Viscoelastic point-of-care coagulation monitoring in patients using herbal medicines and dietary supplements will aid decision making regarding cause of perioperative haemorrhage and need for specific blood products. It will therefore assist with goal-directed management of perioperative haemorrhage. It will also aid the anaesthetist wishing to employ a regional anaesthetic technique in this patient group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dietary Supplements, Bleeding Tendency; Due to Coagulation Defect
Keywords
Dietary supplements, Bleeding tendency
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Five- armed, placebo- controlled ( 4 intervention groups and 1 placebo group)
Masking
ParticipantOutcomes Assessor
Masking Description
Each participant will be blinded to the dietary supplement which they will be taking. The medical technologist doing the ROTEM will be blinded to the dietary supplements as well.
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Ginger
Arm Type
Active Comparator
Arm Description
Ginger ( Zingiber officinale) 4 grams po dly for 14 days
Arm Title
Garlic
Arm Type
Active Comparator
Arm Description
Garlic (Allium sativum) 4-12 mg alliin po dly for 14 days
Arm Title
Ginkgo Biloba
Arm Type
Active Comparator
Arm Description
Ginkgo Biloba 40mg po tds for 14 days
Arm Title
Ginseng
Arm Type
Active Comparator
Arm Description
Ginseng 400mg po dly for 14 days
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo po dly for 14 days
Intervention Type
Dietary Supplement
Intervention Name(s)
Ginger
Intervention Description
Ginger dosage at daily recommended allowance
Intervention Type
Dietary Supplement
Intervention Name(s)
Garlic
Intervention Description
Garlic dosage at daily recommended allowance
Intervention Type
Dietary Supplement
Intervention Name(s)
Ginkgo Biloba
Intervention Description
Ginkgo Biloba dosage at daily recommended allowance
Intervention Type
Dietary Supplement
Intervention Name(s)
Ginseng
Intervention Description
Ginseng dosage at daily recommended allowance
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Daily dosage strategy
Primary Outcome Measure Information:
Title
Platelet dysfunction determined by ROTEM when consuming ginger, garlic, ginkgo biloba and ginseng.
Description
To determine if viscoelastic point-of-care coagulation monitoring (ROTEM) detects abnormalities in platelet function when subjects consume ginger, garlic, ginkgo biloba and ginseng within their recommended daily allowances. ExTEM and FibTEM analysis will be performed and difference in MCF values will determine if there is platelet dysfunction or not.
Time Frame
2-4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 18-60 years
Both males and females
Healthy volunteers
Smokers and Non-smokers
Staff frequenting the theatre complex at Steve Biko Academic Hospital
Exclusion Criteria:
Use of any medication, excluding oral contraceptive pills, in the two week period prior to commencement of the study. Medicines excluded, include aspirin, dietary supplements, herbal teas, anticoagulants and other non-steroidal anti-inflammatory medications. . Oral contraceptive pills were omitted as an exclusion criteria, taking into account that the majority of woman use these. The results of the study will be a better reflection of the effect of these dietary supplements in the modern day woman. Its coagulant properties will be taken into account during data analysis.
History of any chronic medical or psychiatric illness.
Current excessive alcohol intake - more than 14 units a week in woman and more than 21 units a week in men.
Pregnant or lactating mothers.
Possible planned surgery during the study period
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jayde V Wyngaard, MBCHB
Organizational Affiliation
University of Pretoria
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
ROTEM and Dietary Supplements
We'll reach out to this number within 24 hrs